Chemical activators of FLJ13236 can exert their influence through various signaling pathways and cellular processes. Forskolin is a diterpene that directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. This rise in cAMP can subsequently activate protein kinase A (PKA), which is known to phosphorylate target proteins, potentially including FLJ13236, thereby activating it. Similarly, IBMX, by inhibiting phosphodiesterases, prevents cAMP degradation, ensuring the sustained activation of the cAMP-PKA signaling cascade, which can enhance the activation state of FLJ13236. Phorbol 12-myristate 13-acetate (PMA) is another activator that functions through the activation of protein kinase C (PKC). PKC phosphorylates a plethora of proteins within the cell, a process that can extend to members of signaling pathways involving FLJ13236, leading to its activation. Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent protein kinases, which may then directly phosphorylate and activate FLJ13236.
Further, Thapsigargin and A23187 both disrupt calcium homeostasis in different manners but achieve a similar outcome-increased intracellular calcium, which can activate calcium-dependent kinases capable of activating FLJ13236. Bisindolylmaleimide I, although a PKC inhibitor, can lead to compensatory activation of other kinases which might phosphorylate and activate FLJ13236 as part of a broader regulatory response. Calyculin A and Okadaic Acid, as inhibitors of protein phosphatases, lead to an increase in the phosphorylation state of proteins within the cell, which can include the phosphorylation and subsequent activation of FLJ13236. Anisomycin activates stress-activated protein kinases, which have the capacity to phosphorylate and activate FLJ13236 as part of the cellular response to stress. Brefeldin A and Tunicamycin both induce stress within the endoplasmic reticulum, which can initiate signaling pathways that lead to the activation of stress kinases, and these, in turn, can activate FLJ13236 as the cell attempts to mitigate the stress.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX prevents the degradation of cAMP by inhibiting phosphodiesterases, which in turn sustains the activation of cAMP-dependent pathways, potentially increasing the functional activity of FLJ13236. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate and activate proteins in signaling pathways that FLJ13236 is involved in, thus leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that may phosphorylate and activate FLJ13236. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, thereby increasing cytosolic calcium levels and potentially activating calcium-dependent kinases that activate FLJ13236. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, elevating intracellular calcium and potentially activating calcium-dependent kinases that would lead to the activation of FLJ13236. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits PKC, leading to alterations in protein phosphorylation patterns that could result in the compensatory activation of related kinases that activate FLJ13236. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, resulting in increased phosphorylation of proteins and potentially enhancing the phosphorylation and activation of FLJ13236. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid acts as a potent inhibitor of protein phosphatases, which leads to an increase in protein phosphorylation levels that could promote the activation of FLJ13236. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases, which may lead to the phosphorylation and activation of FLJ13236. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus, which can activate stress pathways that may include kinases responsible for the activation of FLJ13236. | ||||||